|
US6326507B1
(en)
|
1998-06-19 |
2001-12-04 |
Trustees Of Dartmouth College |
Therapeutic compounds and methods of use
|
|
EP1142889A1
(en)
|
2000-04-03 |
2001-10-10 |
Pfizer Products Inc. |
Pyrazole derivatives as anti-inflammatory/analgesic agents
|
|
WO2002047611A2
(en)
|
2000-11-28 |
2002-06-20 |
Board Of Regents, The University Of Texas System |
Cddo-compounds and combination therapies thereof
|
|
US7435755B2
(en)
|
2000-11-28 |
2008-10-14 |
The Trustees Of Dartmouth College |
CDDO-compounds and combination therapies thereof
|
|
WO2003027075A2
(en)
|
2001-09-19 |
2003-04-03 |
Pharmacia Corporation |
Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
|
|
US7176237B2
(en)
|
2002-01-15 |
2007-02-13 |
The Trustees Of Dartmouth College |
Tricyclic-bis-enone derivatives and methods of use thereof
|
|
JP2006515859A
(ja)
|
2002-05-13 |
2006-06-08 |
トラスティーズ オブ ダートマス カレッジ |
阻害剤およびその使用法
|
|
EP2298315A1
(en)
*
|
2002-08-28 |
2011-03-23 |
Harbor BioSciences, Inc. |
Therapeutic treatment methods
|
|
WO2006089406A1
(en)
|
2005-02-22 |
2006-08-31 |
Gemin X Biotechnologies Inc. |
Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
|
|
US8299046B2
(en)
|
2006-11-17 |
2012-10-30 |
Trustees Of Dartmouth College |
Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
|
|
US8921340B2
(en)
|
2006-11-17 |
2014-12-30 |
Trustees Of Dartmouth College |
Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
|
|
EP2094651A1
(en)
|
2006-11-17 |
2009-09-02 |
Trustees Of Dartmouth College |
Synthesis and biological activities of new tricyclic-bis-enones (tbes)
|
|
WO2008136838A1
(en)
|
2007-05-04 |
2008-11-13 |
Trustees Of Dartmouth College |
Novel amide derivatives of cddo and methods of use thereof
|
|
WO2009023845A2
(en)
|
2007-08-15 |
2009-02-19 |
The Board Of Regents Of The University Of Texas System |
Combination therapy with synthetic triterpenoids and gemcitabine
|
|
US8088824B2
(en)
|
2007-08-15 |
2012-01-03 |
Reata Pharmaceuticals Inc. |
Forms of CDDO methyl ester
|
|
BRPI0907423A2
(pt)
|
2008-01-11 |
2020-10-27 |
Reata Pharmaceuticals, Inc. |
composto triterpenoide sintético para uso em um método de melhoria da função renal em um indivíduo, e uso do referido composto
|
|
WO2009146218A2
(en)
|
2008-04-18 |
2009-12-03 |
Reata Pharmaceuticals, Inc. |
Compounds including an anti-inflammatory pharmacore and methods of use
|
|
JP5529851B2
(ja)
|
2008-04-18 |
2014-06-25 |
リアタ ファーマシューティカルズ インコーポレイテッド |
抗酸化炎症モジュレーター：ｃ−１７においてアミノ改変およびその他の改変を加えたオレアノール酸誘導体
|
|
MX2010011439A
(es)
|
2008-04-18 |
2011-01-25 |
Reata Pharmaceuticals Inc |
Moduladores de inflamacion antioxidantes: derivados del acido oleanolico homologacion c-17.
|
|
US8071632B2
(en)
|
2008-04-18 |
2011-12-06 |
Reata Pharmaceuticals, Inc. |
Antioxidant inflammation modulators: novel derivatives of oleanolic acid
|
|
KR101713140B1
(ko)
|
2008-04-18 |
2017-03-08 |
리타 파마슈티컬스 잉크. |
Ｃ-환에서 포화된 산화방지성 염증 조절제 올레아놀산 유도체
|
|
US8278311B2
(en)
|
2008-04-28 |
2012-10-02 |
Abbott Laboratories |
Substituted pyrimidine derivatives
|
|
EP2309860B1
(en)
|
2008-07-22 |
2014-01-08 |
Trustees of Dartmouth College |
Monocyclic cyanoenones and methods of use thereof
|
|
WO2010053817A1
(en)
|
2008-11-04 |
2010-05-14 |
Trustees Of Dartmouth College |
Betulinic acid derivatives and methods of use thereof
|
|
SI2395979T1
(sl)
|
2009-02-13 |
2017-12-29 |
Reata Pharmaceuticals, Inc. |
Peroralni farmacevtski sestavki, ki vsebujejo amorfni CDDO-Me, z zapoznelim sproščanjem
|
|
DK2558105T3
(da)
|
2010-04-12 |
2020-01-27 |
Reata Pharmaceuticals Inc |
Bardoxolonmethyl til behandling af fedme
|
|
CN103596929B
(zh)
|
2010-12-17 |
2016-10-19 |
里亚塔医药公司 |
作为抗氧化发炎调节剂的吡唑及嘧啶三环烯酮
|
|
MX348862B
(es)
|
2011-03-11 |
2017-07-03 |
Reata Pharmaceuticals Inc |
Derivados c4-monometil triterpenoides y sus metodos de uso.
|
|
TWI623548B
(zh)
|
2012-04-27 |
2018-05-11 |
瑞塔醫藥有限責任公司 |
齊墩果酸（ｂａｒｄｏｘｏｌｏｎｅ ｍｅｔｈｙｌ）之２，２-二氟基丙醯胺衍生物、多晶型及其使用方法
|
|
WO2013188818A1
(en)
|
2012-06-15 |
2013-12-19 |
Reata Pharmaceuticals, Inc. |
A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
|
|
JP6243428B2
(ja)
|
2012-09-10 |
2017-12-06 |
リアタ ファーマシューティカルズ インコーポレイテッド |
オレアノール酸のｃ１７−アルカンジイルおよびアルケンジイル誘導体ならびにその使用方法
|
|
US9512094B2
(en)
|
2012-09-10 |
2016-12-06 |
Reata Pharmaceuticals, Inc. |
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
|
|
WO2014040073A1
(en)
|
2012-09-10 |
2014-03-13 |
Reata Pharmaceuticals, Inc. |
C13-hydroxy derivatives of oleanolic acid and methods of use thereof
|
|
SMT201700501T1
(it)
|
2012-09-10 |
2017-11-15 |
Reata Pharmaceuticals Inc |
Derivati c17-eteroarilici dell'acido oleanolico e metodi d'uso degli stessi
|
|
EP4736949A2
(en)
|
2013-08-23 |
2026-05-06 |
Reata Pharmaceuticals Holdings, LLC |
Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
|
|
WO2015112792A1
(en)
*
|
2014-01-24 |
2015-07-30 |
Abbvie Inc. |
Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
|
|
CA2975997A1
(en)
|
2015-02-11 |
2016-08-18 |
Merck Sharp & Dohme Corp. |
Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
|
|
EP3256451B1
(en)
|
2015-02-12 |
2021-10-20 |
Reata Pharmaceuticals, Inc. |
Imidazolyl tricyclic enones as antioxidant inflammation modulators
|
|
AR104555A1
(es)
|
2015-05-07 |
2017-07-26 |
Bristol Myers Squibb Co |
SULFONAS TRICÍCLICAS COMO MODULARES DE RORg
|
|
EP3640251B1
(en)
|
2016-10-24 |
2021-12-08 |
Astrazeneca AB |
6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer
|
|
JOP20190144A1
(ar)
|
2016-12-16 |
2019-06-16 |
Janssen Pharmaceutica Nv |
إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
|
|
KR102314286B1
(ko)
|
2016-12-16 |
2021-10-21 |
화이자 인코포레이티드 |
Glp-1 수용체 작용제 및 이의 용도
|
|
JP7291077B2
(ja)
|
2016-12-16 |
2023-06-14 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ｊａｋファミリーのキナーゼの低分子阻害物質
|
|
EP3555050A1
(en)
|
2016-12-16 |
2019-10-23 |
Basf Se |
Pesticidal compounds
|
|
TWI831738B
(zh)
|
2016-12-16 |
2024-02-11 |
美商瑞塔醫藥有限責任公司 |
用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物
|
|
US12060340B2
(en)
|
2018-06-20 |
2024-08-13 |
Reata Pharmaceuticals, Inc |
Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith
|